Literature DB >> 6729144

Detection of leukotriene C4-liked immunoreactivity in tear fluid from subjects challenged with specific allergen.

H Bisgaard, A W Ford-Hutchinson, S Charleson, E Taudorf.   

Abstract

Tear fluid was obtained from allergic subjects from control eyes and eyes challenged with specific allergen and levels of leukotriene C4 (LTC4)-immunoreactivity determined by radioimmunoassay. Formal identification of the leukotrienes released was not possible but the levels of LTC4-immunoreactive material in allergen-challenged tear fluid (4.9 +/- 2.3 ng/ml, n = 9) were significantly higher (p less than 0.01) than those in control tear fluid (0.07 +/- 0.06 ng/ml, n = 9). These results provide evidence that leukotrienes, which account for the biological activity of slow reacting substance of anaphylaxis, may be released in allergic reactions in vivo in man.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6729144     DOI: 10.1016/0090-6980(84)90196-5

Source DB:  PubMed          Journal:  Prostaglandins        ISSN: 0090-6980


  7 in total

Review 1.  Allergic ocular disease. A review of pathophysiology and clinical presentations.

Authors:  L Bielory; P E Goodman; E M Fisher
Journal:  Clin Rev Allergy Immunol       Date:  2001-04       Impact factor: 8.667

2.  Synergistic effects of LTB4 and LTD4 on leukocyte emigration into the guinea pig conjunctiva.

Authors:  C S Spada; D F Woodward; S B Hawley; A L Nieves; L S Williams; B J Feldmann
Journal:  Am J Pathol       Date:  1988-02       Impact factor: 4.307

3.  Conjunctival provocative tests: a model of human ocular allergy.

Authors:  M H Friedlaender
Journal:  Trans Am Ophthalmol Soc       Date:  1989

Review 4.  Leukotrienes in inflammation.

Authors:  M A Bray
Journal:  Agents Actions       Date:  1986-10

5.  Accumulation of leukotriene C4 and histamine in human allergic skin reactions.

Authors:  S F Talbot; P C Atkins; E J Goetzl; B Zweiman
Journal:  J Clin Invest       Date:  1985-08       Impact factor: 14.808

6.  A novel 5-lipoxygenase-activating protein inhibitor, AM679, reduces inflammation in the respiratory syncytial virus-infected mouse eye.

Authors:  Alla Musiyenko; Lucia Correa; Nicholas Stock; John H Hutchinson; Daniel S Lorrain; Gretchen Bain; Jilly F Evans; Sailen Barik
Journal:  Clin Vaccine Immunol       Date:  2009-09-16

Review 7.  Cysteinyl leukotrienes: multi-functional mediators in allergic rhinitis.

Authors:  M Peters-Golden; M M Gleason; A Togias
Journal:  Clin Exp Allergy       Date:  2006-06       Impact factor: 5.018

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.